Beta
252407

A RETROSPECTIVE ANALYSIS OF EPIDEMIOLOGICAL FEATURES AND CLINICAL OUTCOMES OF PATIENTS WITH MALIGNANT PLEURAL MESOTHELIOMA TREATED IN AIN SHAMS CLINICAL ONCOLOGY DEPARTMENT IN TH

Article

Last updated: 26 Dec 2024

Subjects

-

Tags

CLINICAL ONCOLOGY AND NUCLEAR MEDICINE

Abstract

Background: Mesothelioma is a rare tumor strongly associated with exposure to carcinogens, particularly asbestos. The study aimed to detect the epidemiological features of patients with malignant pleural mesothelioma treated in Ain Shams university hospital and different treatment outcomes
Aim of work: To analyze retrospectively epidemiological and clinical outcomes of malignant pleural mesothelioma patients treated in Ain Shams University Hospitals (ASU) in Cairo, Egypt, from 2017 to 2020.
Patients and methods: convenient sampling of 120 patients with malignant pleural mesothelioma. The primary objective was to analyze the epidemiological and demographic data while secondary objectives included calculating overall survival as well as correlation between different clinic-pathological factors and outcome.
Results: 120 participants were included, with a median age of 56.5, male to female ratio of 1:1.14. Incidence was highest in industrial areas Shobra Al Khaimah and Helwan as compared to other areas, 35.8%, 15% and 49.2% respectively. Epithelioid subtype represents 86.6% of the patients, while 6.6% of the patients are biphasic subtype and only 2.5% sarcomatoid subtype.
The most common presenting symptom was dyspnea, followed by chest pain. Only 6.7% of the patients were candidates for surgery whether after chemotherapy or upfront, while 77.5% of the patients were candidates for first line chemotherapy and only 15.8% received radiotherapy, all with palliative intent.
Conclusion: Mesothelioma in Egypt is mainly concentrated in areas of high environmental pollution. We aimed to provide retrospective data of epidemiological, clinic-pathological and outcomes of adult MPM patients. Better environmental control programme would benefit Egypt.

DOI

10.21608/asmj.2022.252407

Keywords

mesothelioma, Epidemiology, risk factors

Authors

First Name

Nada

Last Name

Sadek

MiddleName

Mohamed

Affiliation

Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, Ain Shams University Cairo, Egypt.

Email

-

City

-

Orcid

-

First Name

Nermine

Last Name

Mostafa

MiddleName

-

Affiliation

Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, Ain Shams University Cairo, Egypt.

Email

-

City

-

Orcid

-

First Name

Sherif

Last Name

Ahmed

MiddleName

Hassanien

Affiliation

Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, Ain Shams University Cairo, Egypt.

Email

-

City

-

Orcid

-

First Name

Khaled

Last Name

El-Hakim

MiddleName

NaguibAbd

Affiliation

Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, Ain Shams University Cairo, Egypt.

Email

-

City

-

Orcid

-

First Name

Walid

Last Name

Abdelmonem

MiddleName

-

Affiliation

Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, Ain Shams University Cairo, Egypt.

Email

-

City

-

Orcid

-

First Name

Sherif

Last Name

Abdel-Wahab

MiddleName

Ahmed

Affiliation

Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, Ain Shams University Cairo, Egypt.

Email

-

City

-

Orcid

-

Volume

73

Article Issue

2

Related Issue

35932

Issue Date

2022-06-01

Receive Date

2022-08-01

Publish Date

2022-06-01

Page Start

313

Page End

326

Print ISSN

0002-2144

Online ISSN

2735-3540

Link

https://asmj.journals.ekb.eg/article_252407.html

Detail API

https://asmj.journals.ekb.eg/service?article_code=252407

Order

7

Type

Original Article

Type Code

1,311

Publication Type

Journal

Publication Title

Ain Shams Medical Journal

Publication Link

https://asmj.journals.ekb.eg/

MainTitle

A RETROSPECTIVE ANALYSIS OF EPIDEMIOLOGICAL FEATURES AND CLINICAL OUTCOMES OF PATIENTS WITH MALIGNANT PLEURAL MESOTHELIOMA TREATED IN AIN SHAMS CLINICAL ONCOLOGY DEPARTMENT IN THE PERIOD FROM 2017 TO 2020

Details

Type

Article

Created At

22 Jan 2023